Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension [NA]

View source ↗

Summary

A clinical trial update describing a personalised pharmacometabolomic-guided strategy to optimise treatment for hypertension, currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Birmingham | Conditions: Hypertension | NA | Status: NOT_YET_RECRUITING